Investor
Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili's EndeavorRx shows promise for adults with ADHD.
The company reported a larger net loss in the first quarter that included a $330.3 million noncash goodwill impairment charge.
Diabetes management company Hygieia extended its Series B round, and Autonomize AI, a workflow platform for healthcare and life sciences, also announced funding.
The company also laid off workers in the U.K. and Israel as it shifts focus to the U.S. market.
The company reported $33.3 million in revenue for Q1 2023 and a net loss of $8.8 million.
The Boston-based company will use the investment to accelerate growth and expand its platform.
The funds will be used to expand its reach.
HIMSS23
ONC senior advisor and innovation portfolio lead Stephen Konya, Moffitt Cancer Center VP of digital innovation Santosh Mohan and the Digital Medicine Society CEO Jennifer Goldsack describe their CancerX partnership.
The funds will be used to expand the company's team, further develop its platform and increase partnerships.
Also, online pharmacy MedEasy has acquired its competitor in Bangladesh.